Patents by Inventor Dean P. Andersen

Dean P. Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180369580
    Abstract: Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontophoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
    Type: Application
    Filed: June 29, 2018
    Publication date: December 27, 2018
    Inventors: Mir A. Imran, Dean P. Andersen, Vikram Malhotra, George Andrew Mangogna
  • Patent number: 10035015
    Abstract: Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontophoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: July 31, 2018
    Assignee: InCube Labs, LLC
    Inventors: Mir A. Imran, Dean P. Andersen, Vikram Malhotra, George Andrew Mangogna
  • Patent number: 9237012
    Abstract: Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: January 12, 2016
    Assignee: NeuroPace, Inc.
    Inventor: Dean P Andersen
  • Publication number: 20150209581
    Abstract: Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontophoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
    Type: Application
    Filed: February 20, 2015
    Publication date: July 30, 2015
    Inventors: Mir A. Imran, Dean P. Andersen, Vikram Malhotra, George Andrew Mangogna
  • Publication number: 20150207622
    Abstract: Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
    Type: Application
    Filed: April 1, 2015
    Publication date: July 23, 2015
    Inventor: Dean P. ANDERSEN
  • Patent number: 9026792
    Abstract: Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
    Type: Grant
    Filed: February 27, 2014
    Date of Patent: May 5, 2015
    Assignee: NeuroPace, Inc.
    Inventor: Dean P Andersen
  • Patent number: 8986279
    Abstract: Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontohoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: March 24, 2015
    Assignee: InCube Labs, LLC
    Inventors: Mir Imran, Dean P. Andersen, Vikram Malhotra, George Andrew Mangogna
  • Publication number: 20140200477
    Abstract: Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
    Type: Application
    Filed: February 27, 2014
    Publication date: July 17, 2014
    Applicant: NeuroPace, Inc.
    Inventor: Dean P. ANDERSEN
  • Publication number: 20140185805
    Abstract: Methods and systems for securely exchanging cipher keys between an implantable device and an external device are described. An example method includes: receiving an authorization request from the external device, wherein the authorization request is a request to receive a first cipher key of a cipher key exchange; receiving an indication that a magnet is detected relative to the implantable device, wherein the indication signifies a secure environment for communication between the implantable device and the external device; and after receiving the authorization request and the indication of a detected magnet, generating a first cipher key transmittal instruction, wherein the first cipher key transmittal instruction instructs the first cipher key to be transmitted to the external device by the implantable device.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 3, 2014
    Applicant: NEUROPACE, INC.
    Inventor: Dean P. Andersen
  • Patent number: 8707040
    Abstract: Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: April 22, 2014
    Assignee: NeuroPace, Inc.
    Inventor: Dean P. Andersen
  • Publication number: 20130108046
    Abstract: Establishing secure communication between an implantable medical device and an external device includes: accessing, at the implantable medical device, biological data; utilizing the biological data, at the implantable medical device, to generate a public cryptographic key; and utilizing the public cryptographic key, at the implantable medical device, to generate a private cryptographic key.
    Type: Application
    Filed: October 31, 2011
    Publication date: May 2, 2013
    Inventor: Dean P. ANDERSEN
  • Publication number: 20110196283
    Abstract: Embodiments of the invention provide an architecture, system and methods for optimizing power utilization for transdermal iontophoretic drug delivery which maintain a iontophoretic driving voltage at a reduced or even minimum value to support an iontophoretic delivery current. The reduced voltage reduces the power requirements for a transdermal iontohoretic delivery system during a period of drug delivery. Embodiments of an architecture for implementing this approach can utilize a controller which compares the desired current to the actual current and adjusts the voltage to reduce the amount of power used for iontophoretic drug delivery. The controller can comprise a state machine or microprocessor. Embodiments of the invention are particularly useful for extending the battery life of transdermal iontophoretic drug delivery systems.
    Type: Application
    Filed: February 9, 2011
    Publication date: August 11, 2011
    Inventors: Mir Imran, Dean P. Andersen, Vikram Malhotra, George Andrew Mangogna